Table 3

Discrimination power of mGPS and IMDC in predicting survival outcomes based on Uno’s concordance statistic

OSPFS
EstimateSE*EstimateSE*
mGPS0.63120.04350.57520.0385
IMDC0.61020.03970.55330.0347
  • *SEs are calculated using 5000 perturbation samples.

  • IMDC, International Metastatic Renal Cell Carcinoma Database Consortium; mGPS, modified Glasgow Prognostic Score; OS, overall survival; PFS, progression-free survival.